The years 2014/201548 were the first following implementation of other eligibility criteria that defined co-infection with TB, Hepatitis B, cancer, and HTLV as criteria for starting ART, regardless of WHO stage or CD4 cell count (Supplementary Table S1). The gene discussed is CD4; the disease is coinfection.